JOSE CARLOS
ARMARIO HITA
Profesor Titular de Universidad
Hospital Universitario Reina Sofia
Córdoba, EspañaHospital Universitario Reina Sofia -ko ikertzaileekin lankidetzan egindako argitalpenak (23)
2024
-
Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study
International Journal of Dermatology
2023
-
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results
Clinical and experimental dermatology, Vol. 48, Núm. 9, pp. 991-997
-
Upadacitinib for moderate to severe atopic dermatitis
Immunotherapy, Vol. 15, Núm. 11, pp. 799-808
-
Updated Review on Treatment of Atopic Dermatitis
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 158-167
2022
-
Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders)
Life
-
Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: A cohort study
F1000Research, Vol. 11
-
Guselkumab as a switching strategy after anti-TNFα, anti-IL17, or anti-IL12/23 therapies in moderate-to-severe psoriasis
Dermatologic Therapy, Vol. 35, Núm. 10
-
Guselkumab dosing interval optimization in adult patients with moderate-to-severe psoriasis switching from ustekinumab
Dermatologic Therapy, Vol. 35, Núm. 11
-
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review
Life, Vol. 12, Núm. 8
-
Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis
Life, Vol. 12, Núm. 12
-
Super responders to guselkumab treatment in moderate-to-severe psoriasis: a real clinical practice pilot series
International Journal of Dermatology, Vol. 61, Núm. 8, pp. 1029-1033
-
Validation of a Questionnaire to Assess the Perception of Women with Atopic Dermatitis in Family Planning
International journal of environmental research and public health, Vol. 19, Núm. 17
2021
-
Drug survival of systemic and biological treatments for moderate-to-severe atopic dermatitis in adults: a multicentre retrospective observational study
British Journal of Dermatology
-
Guselkumab: Mid-term effectiveness, drug survival, and safety in real clinical practice
Dermatologic Therapy, Vol. 34, Núm. 2
-
Risankizumab: A pilot study of short-term effectiveness and safety in real clinical practice
Dermatologic Therapy
-
Secukinumab: Drug Survival in Clinical Practice Settings
Actas Dermo-Sifiliograficas, Vol. 112, Núm. 4, pp. 361-364
-
Short-term effectiveness and safety of biologics and small molecule drugs for moderate to severe atopic dermatitis: A systematic review and network meta-analysis
Life, Vol. 11, Núm. 9
2020
-
A Review of the Latest Recommendations on the Management of Chronic Urticaria: A Multidisciplinary Consensus Statement from Andalusia, Spain
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 3, pp. 222-228
-
Brodalumab: short-term effectiveness and safety in real clinical practice
International Journal of Dermatology
-
Drug survival, discontinuation rates, and safety profile of secukinumab in real-world patients: a 152-week, multicenter, retrospective study
International Journal of Dermatology, Vol. 59, Núm. 5, pp. 633-639